For use in regenerative therapies in neonates where large numbers of CMs are required and coculture with heart tissue is unfeasible, a method of chemical-based differentiation of AFSCs to CMs could be highly significant.
← all excerpts
Amniotic fluid collected from vaginal birth as a source of stem cells for clinical applications and disease modeling.
1
—
—